RM Pharma Consulting ApS: Financial statements 2025
CVR: 44193000
Source: annual report 2025, Danish Business Authority
01/10/2024 – 30/09/2025
RM Pharma Consulting ApS (CVR 44193000) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,169,747 and a net result of DKK 114,636. Equity in the 2025 report amounted to DKK 408,834. The solvency ratio was 39.6%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,169,747
- Profit/Loss
- DKK 114,636
- Equity
- DKK 408,834
- Total Assets
- DKK 1,031,895
- Employees
- 2
Official annual report
How creditworthy is RM Pharma Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout RM Pharma Consulting ApS
RM Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2023. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Rami Abdal Monem. The company is owned by Rami Abdal Monem. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 2,169,747 and a net result of DKK 114,636. Equity in the 2025 report amounted to DKK 408,834.